Atıf İçin Kopyala
Ataman S., Borman P., Evcik D., Aydog E., Ayhan F., Yildizlar D., ...Daha Fazla
TURKISH JOURNAL OF RHEUMATOLOGY, cilt.26, sa.4, ss.273-294, 2011 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
26
Sayı:
4
-
Basım Tarihi:
2011
-
Doi Numarası:
10.5606/tjr.2011.046
-
Dergi Adı:
TURKISH JOURNAL OF RHEUMATOLOGY
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
-
Sayfa Sayıları:
ss.273-294
-
Anahtar Kelimeler:
Guidelines, rheumatoid arthritis, treatment, MODIFYING ANTIRHEUMATIC DRUGS, ANTITUMOR-NECROSIS-FACTOR, RANDOMIZED CONTROLLED-TRIAL, COMBINATION DMARD THERAPY, ADALIMUMAB PLUS METHOTREXATE, CLINICAL-PRACTICE GUIDELINES, JOINT PROTECTION PROGRAM, LOW DISEASE-ACTIVITY, QUALITY-OF-LIFE, DOUBLE-BLIND
-
Akdeniz Üniversitesi Adresli:
Evet
Özet
Objectives: Taking new developments in the management of rheumatoid arthritis (RA) and the economic conditions of our country into account, the Turkish League Against Rheumatism (TLAR) aimed to develop national treatment recommendations for the management of RA; thus, they consulted with national experts for their opinions.